Although PDT and PTT have a potential to elicit a robust antitumor immune response, they increase the infiltration of IFN-γ-secreting cells into the TME and IFN-γ upregulates the expression of PD-L1 and IDO-1 by tumor and tumor-associated immune cells. The gene discussed is CD274; the disease is neoplasm.